Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine

Life Sciences

Volumn 135, Issue , 2015, Pages 15-21

  Bonfleur, Maria Lúcia ^a   Borck, Patrícia Cristine ^b   Ribeiro, Rosane Aparecida ^c   Caetano, Luiz Carlos ^a   Soares, Gabriela Moreira ^a   Carneiro, Everardo Magalhães ^b   Balbo, Sandra Lucinei ^a  

^a UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Chemical compounds studied in this article Monosodium glutamate (PubChem CID: 16219392); Taurine (PubChem CID: 1123)

Indexed keywords

ACYL COENZYME A OXIDASE; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID SYNTHASE; GLUTAMATE SODIUM; LIVER ENZYME; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN; TAURINE; TRIACYLGLYCEROL; FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID LIVER LEVEL; LIPID OXIDATION; LIPID STORAGE; LIPOGENESIS; MALE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; RETROPERITONEAL FAT; SUPPLEMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; DIET SUPPLEMENTATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIVER; METABOLISM; PATHOLOGY; WISTAR RAT;

RATTUS;

ANIMALS; DIETARY SUPPLEMENTS; FATTY ACIDS; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIVER; MALE; OBESITY; RATS; RATS, WISTAR; TAURINE;

EID: 84934952812     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.05.019     Document Type: Article

References (55)

1. L.A. Adams, and P. Angulo Treatment of non-alcoholic fatty liver disease Postgrad. Med. J. 82 2006 315 322
2. G. Alberdi, V.M. Rodriguez, M.T. Macarulla, J. Miranda, I. Churruca, and M.P. Portillo Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet Nutrition 29 2013 562 567
3. W.S. Au, H.F. Kung, and M.C. Lin Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38 Diabetes 52 2003 1073 1080
4. S.L. Balbo, P.C. Mathias, M.L. Bonfleur, H.F. Alves, F.J. Siroti, and O.G. Monteiro Vagotomy reduces obesity in MSG-treated rats Res. Commun. Mol. Pathol. Pharmacol. 108 2000 291 296
5. S. Bellentani, F. Scaglioni, M. Marino, and G. Bedogni Epidemiology of non-alcoholic fatty liver disease Dig. Dis. 28 2010 155 161
6. L.L. Bernardis, and B.D. Patterson Correlation between 'Lee index' and carcass fat content in weanling and adult female rats with hypothalamic lesions J. Endocrinol. 40 1968 527 528
7. G. Boden, S. Salehi, P. Cheung, C. Homko, W. Song, and C. Loveland-Jones Comparison of in vivo effects of insulin on SREBP-1c activation and INSIG-1/2 in rat liver and human and rat adipose tissue Obesity 21 2013 1208 1214
8. N. Chalasani, Z. Younossi, J.E. Lavine, A.M. Diehl, E.M. Brunt, and K. Cusi The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Gastroenterology 142 2012 1592 1609
9. X. Chang, H. Yan, J. Fei, M. Jiang, H. Zhu, and D. Lu Berberine reduces methylation of the MTP promoter and alleviates fatty liver induced by a high-fat diet in rats J. Lipid Res. 51 2010 2504 2515
10. Y.Y. Chang, C.H. Chou, C.H. Chiu, K.T. Yang, Y.L. Lin, and W.L. Weng Preventive effects of taurine on development of hepatic steatosis induced by a high-fat/cholesterol dietary habit J. Agric. Food Chem. 59 2011 450 457
11. M. Charlton Nonalcoholic fatty liver disease: a review of current understanding and future impact Clin. Gastroenterol. Hepatol. 2 2004 1048 1058
12. C. Dorn, M.O. Riener, G. Kirovski, M. Saugspier, K. Steib, and T.S. Weiss Expression of fatty acid synthase in nonalcoholic fatty liver disease Int. J. Clin. Exp. Pathol. 3 2010 505 514
13. R.M. Evans, G.D. Barish, and Y.X. Wang PPARs and the complex journey to obesity Nat. Med. 10 2004 355 361
14. J. Folch, M. Lees, and G.H. Sloane Stanley A simple method for the isolation and purification of total lipids from animal tissues J. Biol. Chem. 226 1957 497 509
15. K. Fujita, K. Imajo, Y. Shinohara, Y. Nozaki, K. Wada, and M. Yoneda Novel findings for the development of drug therapy for various liver diseases: liver microsomal triglyceride transfer protein activator may be a possible therapeutic agent in non-alcoholic steatohepatitis J. Pharmacol. Sci. 115 2011 270 273
16. N. Fukuda, A. Yoshitama, S. Sugita, M. Fujita, and S. Murakami Dietary taurine reduces hepatic secretion of cholesteryl ester and enhances fatty acid oxidation in rats fed a high-cholesterol diet J. Nutr. Sci. Vitaminol. 57 2011 144 149
17. S. Fukunishi, T. Sujishi, A. Takeshita, H. Ohama, Y. Tsuchimoto, and A. Asai Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats J. Clin. Biochem. Nutr. 54 2014 39 44
18. C.L. Gentile, A.M. Nivala, J.C. Gonzales, K.T. Pfaffenbach, D. Wang, and Y. Wei Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease Am. J. Physiol. Regul. Integr. Comp. Physiol. 301 2011 R1710 R1722
19. B. Grygiel-Gorniak Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review Nutr. J. 13 2014 17
20. F. Guerrero-Romero, L.E. Simental-Mendia, M. Gonzalez-Ortiz, E. Martinez-Abundis, M.G. Ramos-Zavala, and S.O. Hernandez-Gonzalez The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp J. Clin. Endocrinol. Metab. 95 2010 3347 3351
21. N. Higuchi, M. Kato, M. Tanaka, M. Miyazaki, S. Takao, and M. Kohjima Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease Experimental and Therapeutic Medicine 2 2011 1077 1081
22. M.H. Hoang, Y. Jia, H.J. Jun, J.H. Lee, K.Y. Hwang, and D.W. Choi Taurine is a liver X receptor-alpha ligand and activates transcription of key genes in the reverse cholesterol transport without inducing hepatic lipogenesis Mol. Nutr. Food Res. 56 2012 900 911
23. M.M. Hussain, J. Shi, and P. Dreizen Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly J. Lipid Res. 44 2003 22 32
24. R.J. Huxtable Physiological actions of taurine Physiol. Rev. 72 1992 101 163
25. K.S. Kim, H. Oh da, J.Y. Kim, B.G. Lee, J.S. You, and K.J. Chang Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes Exp. Mol. Med. 44 2012 665 673
26. M. Kohjima, M. Enjoji, N. Higuchi, M. Kato, K. Kotoh, and T. Yoshimoto Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease Int. J. Mol. Med. 20 2007 351 358
27. S.H. Koo Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis Clinical and Molecular Hepatology 19 2013 210 215
28. E. Lima-Cabello, M.V. Garcia-Mediavilla, M.E. Miquilena-Colina, J. Vargas-Castrillon, T. Lozano-Rodriguez, and M. Fernandez-Bermejo Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C Clin. Sci. 120 2011 239 250
29. L. Ma, L.N. Robinson, and H.C. Towle ChREBP∗Mlx is the principal mediator of glucose-induced gene expression in the liver J. Biol. Chem. 281 2006 28721 28730
30. L. Macho, M. Fickova, and Z.S. Jezova Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats Physiological research/Academia Scientiarum Bohemoslovaca 49 Suppl 1 2000 S79 S85
31. P. Mathurin, A. Hollebecque, L. Arnalsteen, D. Buob, E. Leteurtre, and R. Caiazzo Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease Gastroenterology 137 2009 532 540
32. S. Milic, D. Lulic, and D. Stimac Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations World J. Gastroenterol. 20 2014 9330 9337
33. H. Mitsuyoshi, K. Yasui, Y. Harano, M. Endo, K. Tsuji, and M. Minami Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease Hepatol. Res. 39 2009 366 373
34. H. Mochizuki, H. Oda, and H. Yokogoshi Increasing effect of dietary taurine on the serum HDL-cholesterol concentration in rats Biosci. Biotechnol. Biochem. 62 1998 578 579
35. E. Morales-Villegas Dyslipidemia, hypertension and diabetes metaflammation. A unique mechanism for 3 risk factors Curr. Hypertens. Rev. 2014
36. S. Murakami, Y. Kondo, Y. Toda, H. Kitajima, K. Kameo, and M. Sakono Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine Life Sci. 70 2002 2355 2366
37. T. Nagaya, N. Tanaka, T. Suzuki, K. Sano, A. Horiuchi, and M. Komatsu Down-regulation of SREBP-1c is associated with the development of burned-out NASH J. Hepatol. 53 2010 724 731
38. M. Nakamuta, M. Kohjima, S. Morizono, K. Kotoh, T. Yoshimoto, and I. Miyagi Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease Int. J. Mol. Med. 16 2005 631 635
39. T.R. Nardelli, R.A. Ribeiro, S.L. Balbo, E.C. Vanzela, E.M. Carneiro, and A.C. Boschero Taurine prevents fat deposition and ameliorates plasma lipid profile in monosodium glutamate-obese rats Amino Acids 41 2011 901 908
40. N. Nishimura, C. Umeda, H. Ona, and H. Yokogoshi The effect of taurine on plasma cholesterol concentration in genetic type 2 diabetic GK rats J. Nutr. Sci. Vitaminol. 48 2002 483 490
41. H. Noh, H. Lee, E. Kim, L. Mu, Y.K. Rhee, and C.W. Cho Inhibitory effect of a Cirsium setidens extract on hepatic fat accumulation in mice fed a high-fat diet via the induction of fatty acid beta-oxidation Biosci. Biotechnol. Biochem. 77 2013 1424 1429
42. Y. Nozaki, K. Fujita, M. Yoneda, K. Wada, Y. Shinohara, and H. Takahashi Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease J. Hepatol. 51 2009 548 556
43. J.M. Orellana-Gavalda, L. Herrero, M.I. Malandrino, A. Paneda, M. Sol Rodriguez-Pena, and H. Petry Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation Hepatology 53 2011 821 832
44. Perfield JW, 2nd, Ortinau LC, Pickering RT, Ruebel ML, Meers GM, Rector RS. Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice. J. Obes. 2013;2013:296537.
45. L.P. Ren, G.Y. Song, Z.J. Hu, M. Zhang, L. Peng, and S.C. Chen The chemical chaperon 4-phenylbutyric acid ameliorates hepatic steatosis through inhibition of de novo lipogenesis in high-fructose-fed rats Int. J. Mol. Med. 32 2013 1029 1036
46. E.B. Ribeiro, C.M. do Nascimento, I.S. Andrade, A.E. Hirata, and M.S. Dolnikoff Hormonal and metabolic adaptations to fasting in monosodium glutamate-obese rats J. Comp. Physiol. B Biochem. Syst. Environ. Physiol. 167 1997 430 437
47. R.A. Ribeiro, S.L. Balbo, L.P. Roma, R.L. Camargo, L.F. Barella, and E.C. Vanzela Impaired muscarinic type 3 (M3) receptor/PKC and PKA pathways in islets from MSG-obese rats Mol. Biol. Rep. 40 2013 4521 4528
48. B.P. Sampey, A.M. Vanhoose, H.M. Winfield, A.J. Freemerman, M.J. Muehlbauer, and P.T. Fueger Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet Obesity 19 2011 1109 1117
49. N. Shindo, T. Fujisawa, K. Sugimoto, K. Nojima, A. Oze-Fukai, and Y. Yoshikawa Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model J. Hepatol. 52 2010 903 912
50. N. Tsuboyama-Kasaoka, C. Shozawa, K. Sano, Y. Kamei, S. Kasaoka, and Y. Hosokawa Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity Endocrinology 147 2006 3276 3284
51. Z. Wang, Y. Iwasaki, L.F. Zhao, M. Nishiyama, T. Taguchi, and M. Tsugita Hormonal regulation of glycolytic enzyme gene and pyruvate dehydrogenase kinase/phosphatase gene transcription Endocr. J. 56 2009 1019 1030
52. J.R. Wetterau, M.C. Lin, and H. Jamil Microsomal triglyceride transfer protein Biochim. Biophys. Acta 1345 1997 136 150
53. K. Yamamoto, A. Yoshitama, M. Sakono, T. Nasu, S. Murakami, and N. Fukuda Dietary taurine decreases hepatic secretion of cholesterol ester in rats fed a high-cholesterol diet Pharmacology 60 2000 27 33
54. M. Zhang, L.F. Bi, J.H. Fang, X.L. Su, G.L. Da, and T. Kuwamori Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects Amino Acids 26 2004 267 271
55. H. Zheng, S. Li, L. Ma, L. Cheng, C. Deng, and Z. Chen A novel agonist of PPAR-gamma based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance Eur. J. Pharmacol. 659 2011 244 251